Search

Your search keyword '"Herbrecht, Raoul"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Herbrecht, Raoul" Remove constraint Author: "Herbrecht, Raoul" Database Gale General OneFile Remove constraint Database: Gale General OneFile
36 results on '"Herbrecht, Raoul"'

Search Results

1. Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007-2020

2. Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients

3. A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis

4. Factors associated with overall and attributable mortality in invasive aspergillosis

5. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: mycoses study group and European organization for research and treatment of cancer consensus criteria

6. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group

8. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

9. Comparison of 2 studies of treatment of invasive aspergillosis

10. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad Trial)

11. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts

12. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

13. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

15. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

16. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome

17. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases

19. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. (Supplement Article)

20. Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis. (Supplement Article)

21. Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. (Supplement Article)

22. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. (Major Article)

23. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

25. CHOP chemotherapy plus rituximab compared wiht CHOP alone in elderly patients with diffuse largeB-cell lymphoma

26. Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive aspergillosis

28. Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat Trial)

30. Liposomal amphotericin B trial marred by conclusions

31. Halo sign and improved outcome

34. Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt

35. Mycograb for the treatment of invasive candidiasis

36. Introduction to the forum report on advances in the design of antifungal clinical trials. (Supplement Article: Introduction)

Catalog

Books, media, physical & digital resources